Wells Fargo Starts Medidata Solutions (MDSO) at Outperform; Differentiated Player

May 29, 2012 5:15 PM EDT Send to a Friend
Get Alerts MDSO Hot Sheet
Price: $74.10 +2.62%

Rating Summary:
    7 Buy, 3 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 12 | New: 30
Trade MDSO Now!
Wells Fargo initiates coverage on Medidata Solutions (NASDAQ: MDSO) with an Outperform. PT range $38-40.

Analyst, Jamie Stockton, said, "We see MDSO as the most differentiated company in clinical trials software and expect continued market-share gains, especially as it cross-sells more non-Rave solutions. As the company continues to experience revenue growth in the mid-teens range and its deferred revenue stabilizes, we expect it to benefit from being valued on an EV-to-Sales basis like other SaaS plays."

For an analyst ratings summary and ratings history on Medidata Solutions click here. For more ratings news on Medidata Solutions click here.

Shares of Medidata Solutions closed at $28.55 yesterday, with a 52 week range of $14.07-$29.65.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Wells Fargo

Add Your Comment